A figure from the HRS remote monitoring consensus document on staffing challenges with remote monitoring.

Electrophysiology experts issue recommendations for remote monitoring of CIEDs

The Heart Rhythm Society released a new expert consensus statement on the management of remote device clinics for implantable EP devices.

The EBR Systems WiSE leadless cardiac resynchronization therapy (CRT) system. #HRS23

A leadless pacemaker the size of a grain of rice delivers cardiac resynchronization therapy

Results from a pivotal clinical trial presented as a late-breaker at Heart Rhythm 2023 indicate that a new leadless pacemaker technology can deliver cardiac resynchronization therapy in patients who were not able to be treated with conventional CRT and epicardial leads.

Left bundle branch pacing emerges as an alternative to biventricular pacing in two late-breaking trials

The use of left bundle branch area pacing (LBBAP) is growing in electrophysiology implanted devices. Two late-breaking studies at Heart Rhythm 2023 highlight the success of LBBAP as an alternative to the standard of care using biventricular pacing.

Thumbnail

‘Promising’ results as first patients undergo PCI with next-generation pVAD device

The new product from California-based Supira Medical was designed to limit hemolysis and other complications among patients undergoing high-risk PCI or in cardiogenic shock

Thumbnail

Marijuana use linked to much higher risk of peripheral artery disease

New research presented at SCAI Scientific Sessions 2023 suggests that marijuana users should understand the early warning signs of PAD, including feelings of pain and coldness in the leg. 

Abbott TriClip device for TEER

EuroPCR 2023: Late-breaking research examines the latest in TEER, TAVR and PCI outcomes

Catch up on key late-breaking research from Abbott, Edwards Lifesciences and Philips presented at the four-day meeting in Paris. 

Thumbnail

Links to all the late-breaking trials for Heart Rhythm 2023

Heart Rhythm 2023, the society's 44th annual meeting, is scheduled for May 19-21. 

Marcelo DiCarli, MD, chief, division of nuclear medicine and molecular imaging, executive director for the cardiovascular imaging program, Brigham and Women's Hospital, discusses how artificial intelligence (AI) is impacting cardiac imaging.

What is the ROI for adopting AI in cardiac imaging?

Marcelo DiCarli, MD, and Rob Beanlands, MD, discussed the long-term value of investing in the development and implementation of AI technologies.